57 Papers
81 Citations
Yuying Liu is an academic researcher from University of Texas Health Science Center at Houston. The author has contributed to research in topics: Medicine & Lactobacillus reuteri. The author has an hindex of 18, co-authored 44 publications. Previous affiliations of Yuying Liu include University of Texas at Austin.
Chat about Author
Papers
Probiotics in Disease Prevention and Treatment
TL;DR: Future research is needed to identify the optimal probiotic and dose for specific diseases, to address whether the addition of prebiotics (to form synbiotics) would enhance activity, and to determine if defined microbial communities would provide benefit exceeding that of single‐species probiotics.
198
Altered fecal microflora and increased fecal calprotectin in infants with colic.
J. Marc Rhoads,Nicole Y. Fatheree,Johana Norori,Yuying Liu,Joseph F. Lucke,Jon E. Tyson,Michael J. Ferris +6 more
TL;DR: Infants with colic, a condition previously believed to be nonorganic in nature, have evidence of intestinal neutrophilic infiltration and a less diverse fecal microflora.
184
Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-κB signaling in the intestine
TL;DR: Both L. reuteri strains significantly increased survival rate and decreased the incidence and severity of NEC, with optimal effects from DSM 17938, and Cow milk formula feeding produced a similar but milder proinflammatory profile in the intestine that was also ameliorated by 17938.
181
Resetting microbiota by Lactobacillus reuteri inhibits T reg deficiency–induced autoimmunity via adenosine A2A receptors
Baokun He,Thomas K. Hoang,Ting Wang,Michael J. Ferris,Christopher M. Taylor,Xiangjun Tian,Meng Luo,Dat Q. Tran,Jain Zhou,Nina Tatevian,Fayong Luo,Jose G. Molina,Michael R. Blackburn,Thomas Gomez,Stefan Roos,J. Marc Rhoads,Yuying Liu +16 more
TL;DR: It is demonstrated that Foxp3+ T reg cell deficiency results in gut microbial dysbiosis and autoimmunity over the lifespan of scurfy (SF) mouse, and the results reveal that the microbiota–inosine–A2A receptor axis might represent a potential avenue for combatting autoimmune diseases mediated by Treg cell dysfunction.
Probiotics in Autoimmune and Inflammatory Disorders
TL;DR: Several randomized controlled trials have now shown that microbial modification by probiotics may improve gastrointestinal symptoms and multiorgan inflammation in rheumatoid arthritis, ulcerative colitis, and multiple sclerosis.
156